ˆ
A. Marinetti, F. Labrue, B. Pons, S. Jus, L. Ricard, J.-P. Genet
FULL PAPER
procedures. 1H, 13C, and 31P NMR spectra were recorded on a
Bruker AM 400 at 400.13 Hz, 100.6 Hz, and 162 Hz, respectively.
HPLC was performed on a Waters 600 chromatograph equipped
with a variable wavelength detector and Daicel Chiracel OD-H col-
umn. Optical rotations were measured on a PerkinϪElmer 241
polarimeter, with a 1 dm cell. IR spectra were recorded on a Bruker
IFS 48 instrument.
Table 7. Crystal structure determination for compound 2c
Empirical formula
Formula mass
Crystal habit
Crystal dimensions [mm]
Crystal system
C39H56Cl4FeN2P2Ru
913.52
tan needles
0.20 ϫ 0.14 ϫ 0.14
orthorhombic
P212121
9.651(5)
19.366(5)
22.000(5)
90.000(5)
90.000(5)
90.000(5)
4112(3)
Space group
˚
a [A]
General Procedure for the Synthesis of trans-[RuCl2{1,1Ј-
Bis(dialkylphosphetanyl)ferrocene}Py2] (2): A solution of trans-
[RuCl2(NBD)Py2][5] (100 mg, 0.23 mmol) and ligand 1 (0.23 mmol)
in CH2Cl2 (13 mL) was stirred overnight at room temperature. The
solvent was removed under vacuum and the residue was recrys-
tallized from a dichloromethane/pentane mixture to afford com-
plexes 2 as yellow, crystalline solids.
˚
b [A]
˚
c [A]
α [°]
β [°]
γ [°]
3
˚
V [A ]
Z
4
d [g·cmϪ3
F000
]
1.476
1888
1.088
µ [cmϪ1
]
trans-[RuCl2{1,1Ј-Bis[(R,R)-2,4-dimethyl-1-phosphetanyl]ferro-
cene}Py2] (2a): Yield 120 mg, 73%. 31P NMR (CDCl3): δ ϭ 87. 1H
NMR (CDCl3): δ ϭ 9.6 (br., 4 H), 7.60 (m, 2 H), 7.3 (br., 4 H),
5.14 (br. s, 2 H, CHcp), 4.50 (m, J ഠ 1 Hz, 4 H, CHcp), 4.34 (m,
J ഠ 1 Hz, 2 H, CHcp), 2.66 (m, 2 H), 2.40 (m, 4 H), 1.79 (m, 2 H),
Absorption corrections
0.8626
0.8118 min
max
KappaCCD
Mo-Kα
Diffractometer
X-ray source
˚
λ [A]
0.71069
3
3
1.28 (dd, JH,H ϭ 7.7, JP-H ϭ 16.4 Hz, 6 H, CH3), 0.92 (dd,
3JH,H ϭ 6.3, 3JP-H ϭ 14.4 Hz, 6 H, CH3) ppm. 13C NMR (CDCl3,
100 MHz): δ ϭ 152.6 (br., CHPy), 152.1 (br., CHPy), 136.0 (CHPy),
123.6 (br., CHPy), 123.4 (br., CHPy), 77.6 (t, J ϭ 7.8 Hz, CHCp),
74.0 (t, J ϭ 3.4 Hz, CHCp),73.0 (m, AXXЈ, CCpP), 72.0 (CHCp),
71.0 (t, J ϭ 1.8 Hz, CHCp), 40.1 (t, J ϭ 7.6 Hz, CH2), 32.0 (m,
Monochromator
T [K]
Scan mode
graphite
150.0(10)
phi
Maximum q
hkl ranges
Reflections measured
30.02
Ϫ13 13; Ϫ27 27; Ϫ30 30
11960
AXXЈ, PCH), 30.2 (m, AXXЈ, PCH), 18.8 (CH3), 17.5 (t, J ϭ Independent reflections
11960
0.0000
11161
Ͼ 2σ(I)
Fsqd
mixed
450
24
20.0965
0.0353
0.006(17)
0.0380; 5.3251
1.072
Rint
2.3 Hz, CH3) ppm. [α]D ϭ Ϫ782 (c ϭ 0.2, CHCl3). C30H38Cl2FeN2-
P2Ru (716.028): calcd. C 50.30, H 5.35, N 3.91; found C 50.66, H
5.96, N 3.82.
Reflections used
Criterion
Refinement type
Hydrogen atoms
Parameters refined
Reflections / parameter
wR
trans-[RuCl2{1,1Ј-Bis[(R,R)-2,4-diethyl-1-phosphetanyl]ferro-
cene}Py2] (2b): Yield 124 mg, 70%. 31P NMR (CDCl3): δ ϭ
82 ppm. 1H NMR (CDCl3): δ ϭ 9.6 (br., 4 H), 7.60 (t, JH,H
ϭ
R1
7.4 Hz, 2 H,CH), 7.3Ϫ7.0 (br., 4 H, CH), 5.10 (s, 2 H, CHcp), 4.50
(s br, 4 H, CHcp), 4.32 (m, 2 H, CHcp), 2.77 (br., 2 H), 2.40 (br., 2
H), 2.22 (m, 2 H), 2.04Ϫ1.95 (m, 4 H), 1.70 (m, 2 H), 0.87 (m, 4
Flack’s parameter
Weighs a, b1
GoF
3
3
Ϫ3
H), 0.79 (t, JH,H ϭ 6.9 Hz, 6 H, CH3), 0.57 (t, JH,H ϭ 7.4 Hz, 6
H, CH3) ppm. 13C NMR (CDCl3, 100 MHz): δ ϭ 152.4 (br.,
CHPy), 136.0 (CHPy), 123.4 (br., CHPy), 77.5 (t, J ϭ 7.8 Hz, CHCp),
74.0 (t, J ϭ 3.4 Hz, CHCp), 73.5 (m, AXXЈ, CCpP), 72.0 (CHCp),
70.8 (CHCp), 39.2 (m, AXXЈ, PCH), 37.6 (m, AXXЈ, PCH), 34.0
(t, J ϭ 7.3 Hz, CH2), 25.7 (CH2CH3), 23.8 (CH2CH3), 13.0 (t, J ϭ
7.5 Hz, CH3), 12.0 (t, JP,C ϭ 5.9 Hz, CH3) ppm. [α]D ϭ Ϫ907 (c ϭ
0.5, CHCl3). C34H46Cl2FeN2P2Ru (772.091): calcd. C 52.86, H
6.00, N 3.63; found C 52.41, H 6.32, N 3.76.
˚
difference peak / hole [e A
]
0.767(0.090) / Ϫ0.944(0.090)
General Procedure for Hydrogenations Carried out with Complexes
2 as Catalyst Precursors: Hydrogenation experiments were carried
out at a 1 mmol scale. The ruthenium complex 2 (1·10Ϫ2 mmol)
was weighed into a small glass reactor fitted with a rubber septum
and flushed with argon. Degassed MeOH (1 mL) and then a solu-
trans-[RuCl2{1,1Ј-Bis[(S,S)-2,4-diisopropyl-1-phosphetanyl]ferro- tion of HBraq in MeOH (0.16 , 0.25 mL, 4 equivalents) were ad-
cene}Py2] (2c): Yield 105 mg (55%). 31P NMR (CDCl3): δ ϭ 71.
ded with stirring at room temperature. After a few minutes, the
1H NMR (CDCl3): δ ϭ 9.68 (br., 2 H, CHPy), 9.61 (br., 2 H, CHPy), substrate was introduced by syringe. The reaction vessel was placed
7.57 (t, JH,H ϭ 7.2 Hz, 2 H, CHPy), 7.19 (br., 2 H, CHPy), 7.09 (br.,
2 H, CHPy), 5.29 (s, 2 H, CHCp), 4.51 (s, 2 H, CHCp), 4.45 (s, 2 H,
in a stainless steel autoclave under argon. The argon atmosphere
was replaced by hydrogen at the given pressure. The reaction was
CHCp), 4.28 (m, Jഠ2 Hz, 2 H, CHCp), 3.10 (m, 2 H), 2.77 (m, 2 allowed to proceed for 24Ϫ48 h at the temperature given in Table 3.
3
1
H), 2.0 (m, 4 H), 1.75 (m, 2 H), 1.44 (m, 2 H), 1.05 (d, JH,H
ϭ
Conversion rates were determined by H NMR spectroscopy. The
3
6.5 Hz, 6 H, CH3), 0.79 (d, JH,H ϭ 6.6 Hz, 6 H, CH3), 0.59 (d, enantiomeric excesses of the final alcohols were determined by chi-
3JH,H ϭ 6.7 Hz, 6 H, CH3), 0.56 (d, JH,H ϭ 6.6 Hz, 6 H, CH3). ral CG and the absolute configurations were assigned from the GC
3
13C NMR (CDCl3, 100 MHz): δ ϭ 153.7 (CHPy), 153.0 (CHPy), retention times by comparison with known samples. Methyl 3-
135.9 (CHPy), 123.8 (CHPy), 123.1 (CHPy), 77.9 (CHCp), 73.7 hydroxybutyrate: Lipodex A, flow 1 mL·minϪ1, initial temperature
(CHCp), 73.2 (CCpP), 72.4 (CHCp), 70.3 (CHCp), 46.4 (m, PCH), 35 °C (30 min), rate 1 °C·minϪ1, final temperature 70 °C; retention
44.0 (m, PCH), 29.2 (CH), 27.8 (CH2), 24.5 (CH3), 23.5 (CH3), times 45 (S) and 48 (R) min. Ethyl 4-methyl-3-hydroxypentanoate:
19.8 (CH3), 19.2 (CH3) ppm. For crystal data see Table 7.
Lipodex A, flow 1 mL·minϪ1, initial temperature 50 °C (5 min),
2588
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2003, 2583Ϫ2590